YOU SEARCHED BY...

Remove all

SEARCH BY...

Country

Contract Service Directory


Jet Pulverizer





Company Headquarters

1255 North Church Street
Moorestown, NJ 08057
United States

Contract Service Directory

    Related Content

    • Breaking News | Industry News
      Melinta Buys Infectious Disease Unit from The Medicines Company

      Melinta Buys Infectious Disease Unit from The Medicines Company

      The deal is worth well over $200M, not including future milestones and royalties
      11.29.17
    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration

      HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration

      HitGen says the partnership could speed up the provision of innovative medicines
      11.29.17
    • Collaborations & Alliances | Packaging & Tracking | Serialization
      Systech, NKP Pharma Partner to Expand Presence in India

      Systech, NKP Pharma Partner to Expand Presence in India

      The goal of the collaboration is unified serialization solutions in India that also meet various requirements
      11.22.17
    • APIs | cGMP Manufacture | Industry News
      Cambrex Completes Small Scale Capacity Expansion

      Cambrex Completes Small Scale Capacity Expansion

      Installs two 500-gallon glass lined reactors, creates a third small scale work center at Charles City, IA plant
      11.08.17
    • cGMP Manufacture | Information Technology
      Flexible Manufacturing Strategies and Data Integrity

      Flexible Manufacturing Strategies and Data Integrity

      Making processes integral with your data handling ability
      Emil W. Ciurczak, DoraMaxx Consulting 11.07.17
    • Bio News | cGMP Manufacture | Industry News
      Celonic Acquires Glycotope’s Bio-Mfg. Facility in Heidelberg

      Celonic Acquires Glycotope’s Bio-Mfg. Facility in Heidelberg

      Expands GMP manufacturing assets and capacity for late-stage and commercial supply
      11.03.17
    • APIs | Breaking News | Facilities | Industry News
      Sterling Expands API Capabilities

      Sterling Expands API Capabilities

      Invests £6 million to strengthen and expand its milling, micronization and solid form capabilities
      10.24.17
    • Drug Development | Industry News
      CPhI Report Addresses Battle Between Innovators and Biogenerics

      CPhI Report Addresses Battle Between Innovators and Biogenerics

      Regulation shifting due to increased data dependence, regulatory oversight is slowing six sigma, forecasts generic growth
      10.24.17
    • cGMP Manufacture | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Tulex Completes NJ Development and Manufacturing Facility

      Tulex Completes NJ Development and Manufacturing Facility

      cGMP facility capable of handling solvent processing and Wurster coating for commercial scale oral solid and liquid dose
      10.13.17
    • Aseptic Processing | Injectables
      Sterile Manufacturing: Future Trends and Challenges

      Sterile Manufacturing: Future Trends and Challenges

      By the middle of this century, biopharmaceuticals are set to overtake all other pharma sales
      Igor Gorsky, Concordia Valsource 10.11.17
    • cGMP Manufacture | Drug Development | Regulatory Affairs
      Contracting & Outsourcing Session Highlights and Key Takeaways

      Contracting & Outsourcing Session Highlights and Key Takeaways

      Insight into CMO Trends, Biotrends, Manufacturing Compliance, FDA Quality Agreements, and CMO Oversight
      Kristin Brooks, Contract Pharma 10.09.17
    • Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best practices for a competitive market
      Jerry Martin and Michiel Ultee 09.06.17
    • Regulatory Affairs | Serialization
      Serialization Validation: Right Fitting Your Strategy With a CMO

      Serialization Validation: Right Fitting Your Strategy With a CMO

      There are three key factors for manufacturers to evaluate as they define and refine their validation and testing approach.
      Linda Kristoffersen and David Colombo, KPMG Life Science Advisors 09.01.17
    • Clinical Trials | Drug Development
      Cancer Trials in the New Age of Drug Development

      Cancer Trials in the New Age of Drug Development

      Insights into the rapid pace of new drug approvals and the implications for pharma/biopharma companies
      08.21.17
    • Breaking News | cGMP Manufacture | Industry News
      FDA Reauthorization Act Signed into Law

      FDA Reauthorization Act Signed into Law

      Renews four major user fee agreements between industry and FDA through FY2022
      08.21.17
    • Industry News | Inspections
      Valeant

      Valeant's Tampa Facility Receives FDA VAI Classification

      Following collaboration with FDA, issues related to a cGMP inspection are being resolved
      08.17.17
    • Breaking News | cGMP Manufacture | Drug Development | Industry News | Regulatory Affairs
      Senate Passes FDA Reauthorization Act

      Senate Passes FDA Reauthorization Act

      Aims to allow faster approval of generic drugs and modifies fee structure for various stakeholders
      08.04.17
    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News

      Invenra Enters Antibody Collaboration with Merck

      Will identify therapeutic antibodies against challenging target
      07.19.17